A study has shown that measles-containing vaccines such as measles-mumps-rubella vaccine (MMR), with or without the varicella vaccine (V), do not increase the risk of febrile seizures.
A team at the University of Saskatchewan, along with VIDO-InterVac, is developing a nasal vaccine against respiratory syncytial virus that shows promise in the lab.
A paper presented to the American Academy of Dermatology looked at the effectiveness of a booster shot of a VZV vaccine.
An experimental malaria vaccine could prevent the transmission of malaria from mosquitoes to humans.
There is currently no chlamydia vaccine, but an Indiana University researcher has been given $2.3 million to try to create one.
A new TB vaccine is expected to complete the first advanced clinical trials in South Africa in 2013.
iBio's shares have jumped 21% with the announcement that it has completed the first Phase I clinical trial of its plant-based vaccine for H1N1 influenza.
It seems that the prolonged whooping cough epidemic that's swept Australia is caused by a new strain that is evading the protection given by the vaccine.
PaxVax's single-dose oral cholera vaccine has been cleared by the U.S. FDA to go into Phase III trials. The vaccine, known as PXVX-0200, is a live, attenuated vaccine and is already available in 6 countries.
While vaccines in some form or another have been used since the 16th century, there are still areas of unmet need. "The world still has no vaccine for HIV/AIDS and hepatitis C, and there's need for a better vaccine against influenza," as Australian Nobel Laureate Peter Doherty told The Times of India.